
  • HOME
  • WHAT I DO
  • RECENT PROJECTS
  • RECOMMENDATIONS
  • CONTACT
  • WHAT I DO
  • RECENT PROJECTS
  • RECOMMENDATIONS
  • CONTACT

What’s in the new EU Clinical Trial Regulation? Part 2: New reporting requirements

By - Anne McDonough3rd Jul 2014

Article 52 requires reporting of serious breaches of the regulation or of the protocol.  A serious breach is defined in much the same way that it was in the UK legislation: a breach likely to affect to a significant degree the safety and rights of a subject or the reliability and robustness of the data… read more

Recent Comments
  • Laura Miller on Some Questions from Paul Krugman
Recent Posts
  • Thanks, BBC, but please try harder!
  • What’s in the new EU Clinical Trial Regulation? Part 3: What does it mean for medical writers?
  • Another kind of pharmaceutical consulting?
  • What’s in the new EU Clinical Trial Regulation? Part 2: New reporting requirements
  • Some Questions from Paul Krugman
Categories
  • European Union
  • Medical research
  • Regulatory
  • Writing
Tags
Clinical Study Report clinical trial registration Clinical Trial Regulation Ebola European Union harmonisation HIV inspection reports layperson summary nonclinical research safety reporting serious breaches urgent safety measures
Meta
  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

Anne McDonough - Medical Writing

e: Anne@McDonoughCR.com - m: +44 (0)7810 647 595

Connect with me on LinkedIn